Progress in adjuvant therapy decision-making after endoscopic resection of early esophageal cancer
Feng Lingling1, Men Yu2, Hui Zhouguang2
1Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Shenzhen 518116,China; 2Department of VIP Medical Servicess, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100021,China
Abstract：Both endoscopic resection and surgery are the common treatment modes for early esophageal cancer. Compared with radical surgery,endoscopic resection has the advantages of less trauma,quicker recovery,lower cost,less complications,the preservation of the normal anatomy,the physiological function of the esophagus,and higher postoperative quality of life. For patients with a high risk of lymph node metastasis, endoscopic resection alone can lead to inadequate treatment,which need adjuvant therapies. Currently, the common adjuvant therapies consist of adjuvant radiochemotherapy and adjuvant radiochemotherapy combined with surgery. How to combine endoscopic resection with adjuvant therapy to bring maximal benefits to patients has become the hot topic in the field of clinical researches. In this article, the current research status,progress and challenges in the combination of endoscopic resection and adjuvant therapy for the treatment of high-risk patients were reviewed.
Feng Lingling,Men Yu,Hui Zhouguang. Progress in adjuvant therapy decision-making after endoscopic resection of early esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2019, 28(11): 867-871.
[1] Chen W,Zheng R,Baade PD,et al. Cancer staTistics in China,2015[J]. Cancer J Clin,2016,66(2):115-132. DOI:10.3322/caac.21338. [2] Lu CL,Lang HC,Luo JC,et al. Increasing trend of the incidence of esophageal squamous cell carcinoma,but not adenocarcinoma,in Taiwan[J]. Cancer Caus Cont,2010,21(2):269-274. DOI:10.1007/s10552-009-9458-0. [3] Kajiyama Y. New Japanese classification of esophageal cancer (11th ed)[J]. Gan To Kagaku Ryoho,2016,43(9):1049-1052. [4] Ohashi S,Miyamoto S,Kikuchi O,et al. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma[J]. Gastroenterology,2015,149(7):1700-1715. DOI:10.1053/j.gastro.2015.08.054. [5] Merkow RP,Bilimoria KY,Keswani RN,et al. Treatment trends,risk of lymph node metastasis,and outcomes for localized esophageal cancer[J]. J Nat Cancer Instit,2014,106(7):1-8. DOI:10.1093/jnci/dju133. [6] Akutsu Y,Uesato M,Shuto K,et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma:a retrospective analysis of 295 patients[J]. Ann Surg,2013,257(6):1032-1038. DOI:10.1097/SLA.0b013e31827017fc. [7] Park JS,Youn YH,Park JJ,et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal squamous neoplasms[J]. Clin Endosc,2016,49(2):168-175. DOI:10.5946/ce.2015.080. [8] Sgourakis G,Gockel I,Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms:a systematic review[J]. World J Gastroenterol,2013,19(9):1424-1437. DOI:10.3748/wjg.v19.i9.1424. [9] Pauthner M,Haist T,Mann M,et al. Surgical therapy of early carcinoma of the esophagus[J]. Viszeralmedizin,2015,31(5):326-330. DOI:10.1159/000441049. [10] Li B,Chen H,Xiang J,et al. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma[J]. J Thorac Cardiovasc Surg,2013,146(5):1198-1203. DOI:10.1016/j.jtcvs.2013.07.006. [11] Gockel I,Sgourakis G,Lyros O,et al. Risk of lymph node metastasis in submucosal esophageal cancer:a review of surgically resected patients[J]. Exp Rev Gastroenterol Hepatol,2011,5(3):371-384. DOI:10.1586/egh.11.33. [12] Briez N,Piessen G,Bonnetain F,et al. Open versus laparoscopically-assisted oesophagectomy for cancer:a multicentre randomised controlled phase Ⅲ trial-the MIRO trial[J]. BMC Cancer,2011,11(310):1-8. DOI:10.1186/1471-2407-11-310. [13] Mannath J,Ragunath K. Role of endoscopy in early oesophageal cancer[J]. Nat Rev Gastroenterol Hepatol,2016,13(12):720-730. DOI:10.1038/nrgastro.2016.148. [14] Shimizu Y,Kato M,Yamamoto J,et al. EMR combined with chemoradiotherapy:a novel treatment for superficial esophageal squamous-cell carcinoma[J]. Gastrointest Endosc,2004,59(2):199-204. DOI:10.1016/S0016-5107(03)02688-9. [15] Kuwano H,Nishimura Y,Oyama T,et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus april 2012 edited by the Japan esophageal society[J]. J Japan Esophag Soci,2015,12(1):1-30. DOI:10.1007/s10388-014-0465-1. [16] NCCN clinical practice guidelines in oncology:esophageal and esophagogastric junction cancers[DB][2018-09-01].http://www.nccn.org. [17] Choi JY,Park YS,Jung HY,et al. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma[J]. Gastrointest Endosco,2011,73(5):881-889,889.e881-882. DOI:10.1016/j.gie.2010.12.028. [18] Dubecz A,Kern M,Solymosi N,et al. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer[J]. Ann Thorac Surg,2015,99(6):1879-1886. DOI:10.1016/j.athoracsur.2015.02.112. [19] Motoyama S,Jin M,Matsuhashi T,et al. Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal,but pathologically submucosal,squamous cell carcinoma of the esophagus[J]. Surg Today,2013,43(6):638-642. DOI:10.1007/s00595-012-0295-5. [20] Old OJ,Isabelle M,Barr H. Staging early esophageal cancer[J]. Adv Exper Med Biol,2016,908(1):161-181. DOI:10.1007/978-3-319-41388-4_9. [21] Lei J,Tian Y,Zhu S C,et al. Preliminary study of IVIM-DWI and DCE-MRI in early diagnosis of esophageal cancer[J]. Euro Rev Medi Pharmacol Sci,2015,19(18):3345-3350. [22] Zheng H,Ren W,Pan X,et al. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy:a pilot study[J]. J Magnet Res Imag,2018,48(2):349-358. DOI:10.1002/jmri.25934. [23] Thosani N,Singh H,Kapadia A,et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers:a systematic review and meta-analysis[J]. Gastrointest Endosc,2012,75(2):242-253. DOI:10.1016/j.gie.2011.09.016. [24] Akutsu Y,Kato K,Igaki H,et al. The prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal cancer:from the results of JCOG0502,a prospective multicenter study[J]. Ann Surg,2016,264(6):1009-1015. DOI:10.1097/sla.0000000000001557. [25] Ikeda A,Hoshi N,Yoshizaki T,et al. Endoscopic submucosal dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion[J]. Int Med,2015,54(22):2803-2813. DOI:10.2169/internalmedicine.54.3591. [26] Qin X,He S,Zhang Y,et al. Diagnosis and staging of superficial esophageal precursor based on pre-endoscopic resection system comparable to endoscopic resection[J]. BMC cancer,2014,14:774. DOI:10.1186/1471-2407-14-774. [27] Pouw RE,Heldoorn N,Alvarez-Herrero L,et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases[J]. Gastrointest Endosc,2011,73(4):662-668. DOI:10.1016/j.gie.2010.10.046. [28] Uno K,Koike T,Kusaka G,et al. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma[J]. Dis Esophagus,2017,30(6):1-8. DOI:10.1093/dote/dox005. [29] Kudou M,Shiozaki A,Fujiwara H,et al. Efficacy of additional surgical resection after endoscopic submucosal dissection for superficial esophageal cancer[J]. Anticancer Res,2017,37(9):5301-5307. DOI:10.21873/anticanres.11956. [30] Motoori M,Yano M,Ishihara R,et al. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer[J]. Ann Surg Oncol,2012,19(7):2135-2141. DOI:10.1245/s10434-012-2231-8. [31] D′Journo X B,Michelet P,Dahan L,et al. Indications and outcome of salvage surgery for oesophageal cancer[J]. Euro J Cardio-thoracic Surg,2008,33(6):1117-1123. DOI:10.1016/j.ejcts.2008.01.056. [32] Tsujii Y,Nishida T,Nishiyama O,et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms:a multicenter retrospective cohort study[J]. Endoscopy,2015,47(9):775-783. DOI:10.1055/s-0034-1391844. [33] Nagami Y,Ominami M,Shiba M,et al. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia[J]. Dig Liver Dis,2017,49(4):427-433. DOI:10.1016/j.dld.2016.12.009. [34] Uchinami Y,Myojin M,Takahashi H,et al. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa[J]. Radiat Oncol,2016,11(84):1-9. DOI:10.1186/s13014-016-0660-4. [35] Ariga T,Ogawa K,Shimoji H,et al. Radical radiotherapy for superficial esophageal cancer:impact of clinical N stage on survival[J]. Anticancer Res,2012,32(8):3371-3376. DOI:10.1016/j.ijrobp.2011.06.526. [36] Yamashina T,Ishihara R,Nagai K,et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma[J]. Am J Gastroenterol,2013,108(4):544-551. DOI:10.1038/ajg.2013.8. [37] Koide Y,Kodaira T,Tachibana H,et al. Clinical outcome of definitive radiation therapy for superficial esophageal cancer[J]. Jpn J Clin Oncol,2017,47(5):393-400. DOI:10.1093/jjco/hyx021. [38] Lee D,Moon S,Cho K,et al. Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer[J]. Radiat Oncol J,2017,35(3):241-248. DOI:10.3857/roj.2017.00458. [39] Murakami Y,Takahashi I,Nishibuchi I,et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0)[J]. Int J Clin Oncol,2015,20(5):897-904. DOI:10.1007/s10147-015-0819-2. [40] Kawaguchi G,Sasamoto R,Abe E,et al. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer[J]. Radiat Oncol,2015,10(31):1-7. DOI:10.1186/s13014-015-0337-4. [41] Kato H,Sato A,Fukuda H,et al. A phase Ⅱ trial of chemoradiotherapy for stage Ⅰ esophageal squamous cell carcinoma:Japan clinical oncology group study (JCOG9708)[J]. Jpn J Clin Oncol,2009,39(10):638-643. DOI:10.1093/jjco/hyp069. [42] Honda K,Akiho H. Endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms[J]. World J Gastrointest Pathophysiol,2012,3(2):44-50. DOI:10.4291/wjgp.v3.i2.44. [43] Hamada K,Ishihara R,Yamasaki Y,et al. Efficacy and safety of endoscopic resection followed by chemoradiotherapy for superficial esophageal squamous cell carcinoma:a retrospective study[J]. Clin Transl Gastroenterol,2017,8:e110. DOI:10.1038/ctg.2017.36. [44] Hisano O,Nonoshita T,Hirata H,et al. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control[J]. Radiat Oncol,2018,13(1):14. DOI:10.1186/s13014-018-0960-y. [45] Shah R,Willingham F. Endoscopic Resection for Early-Stage Esophageal Cancer,Are We There for Squamous As Well?[J]. Clin Transl Gastroenterol,2017,8(12):e130. DOI:10.1038/ctg.2017.56. [46] Muto M,Minashi K,Nihei K,et al. Efficacy of combined endoscopic resection and chemoradiotherapy for clinical stage Ⅰ esophageal squamous cell carcinoma (ESCC):a single-arm confirmatory study (JCOG0508)[J]. J Clin Oncol,2016,34(15 Suppl):4013-4013. DOI:10.1200/JCO.2016.34.15_suppl.4013. [47] Wang S,Huang Y,Xie J,et al. Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis[J]. Surg Endosc,2018,32(3):1441-1448. DOI:10.1007/s00464-017-5830-4. [48] Jiang D,Li X,Wang H,et al. A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions[J]. Surg Endosc,2017,31(5):2122-2130. DOI:10.1007/s00464-016-5208-z. [49] Jing W,Guo H,Kong L,et al. Clinical outcomes of elderly patients (>/=70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy:a retrospective analysis from a single cancer institute[J]. Med,2016,95(50):e5630. DOI:10.1097/md.0000000000005630. [50] Barnes JA,Willingham FF. Endoscopic management of early esophageal cancer[J]. J Clin Gastroenterol,2015,49(8):638-646. DOI:10.1097/mcg.0000000000000353. [51] Allum WH,Bonavina L,Cassivi SD,et al. Surgical treatments for esophageal cancers[J]. Ann New York Acad Sci,2014,1325:242-268. DOI:10.1111/nyas.12533. [52] Best LM,Mughal M,Gurusamy KS. Non-surgical versus surgical treatment for oesophageal cancer[J/CD]. Cochrane Data System Rev,2016,3:Cd011498. DOI:10.1002/14651858.
2019, Vol. 28 
